Musculoskeletal tissue engineering by endogenous stem/progenitor cells

Hemin Nie, Chang Hun Lee, Jiali Tan, Chuanyong Lu, Avital Mendelson, Mo Chen, Mildred C. Embree, Kimi Kong, Bhranti Shah, Shuang Wang, Shoko Cho, Jeremy Mao

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

From its inception, tissue engineering has had three tenets: cells, biomaterial scaffolds and signaling molecules. Among the triad, cells are the center piece, because cells are the building blocks of tissues. For decades, cell therapies have focused on the procurement, manipulation and delivery of healthy cells for the treatment of diseases or trauma. Given the complexity and potential high cost of cell delivery, there is recent and surging interest to orchestrate endogenous cells for tissue regeneration. Biomaterial scaffolds are vital for many but not all, tissue-engineering applications and serve to accommodate or promote multiple cellular functions. Signaling molecules can be produced by transplanted cells or endogenous cells, or delivered specifically to regulate cell functions. This review highlights recent work in tissue engineering and cell therapies, with a focus on harnessing the capacity of endogenous cells as an alternative or adjunctive approach for tissue regeneration.

Original languageEnglish (US)
Pages (from-to)665-676
Number of pages12
JournalCell and Tissue Research
Volume347
Issue number3
DOIs
StatePublished - Mar 1 2012
Externally publishedYes

Fingerprint

Tissue Engineering
Stem Cells
Cell- and Tissue-Based Therapy
Biocompatible Materials
Regeneration
Costs and Cost Analysis
Wounds and Injuries

Keywords

  • Cell delivery
  • Cell homing
  • Progenitor cells
  • Stem cells
  • Tissue engineering
  • Tissue regeneration

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Cell Biology

Cite this

Nie, H., Lee, C. H., Tan, J., Lu, C., Mendelson, A., Chen, M., ... Mao, J. (2012). Musculoskeletal tissue engineering by endogenous stem/progenitor cells. Cell and Tissue Research, 347(3), 665-676. https://doi.org/10.1007/s00441-012-1339-2

Musculoskeletal tissue engineering by endogenous stem/progenitor cells. / Nie, Hemin; Lee, Chang Hun; Tan, Jiali; Lu, Chuanyong; Mendelson, Avital; Chen, Mo; Embree, Mildred C.; Kong, Kimi; Shah, Bhranti; Wang, Shuang; Cho, Shoko; Mao, Jeremy.

In: Cell and Tissue Research, Vol. 347, No. 3, 01.03.2012, p. 665-676.

Research output: Contribution to journalReview article

Nie, H, Lee, CH, Tan, J, Lu, C, Mendelson, A, Chen, M, Embree, MC, Kong, K, Shah, B, Wang, S, Cho, S & Mao, J 2012, 'Musculoskeletal tissue engineering by endogenous stem/progenitor cells', Cell and Tissue Research, vol. 347, no. 3, pp. 665-676. https://doi.org/10.1007/s00441-012-1339-2
Nie, Hemin ; Lee, Chang Hun ; Tan, Jiali ; Lu, Chuanyong ; Mendelson, Avital ; Chen, Mo ; Embree, Mildred C. ; Kong, Kimi ; Shah, Bhranti ; Wang, Shuang ; Cho, Shoko ; Mao, Jeremy. / Musculoskeletal tissue engineering by endogenous stem/progenitor cells. In: Cell and Tissue Research. 2012 ; Vol. 347, No. 3. pp. 665-676.
@article{662d18caac684f9fbf24f9fa6971c0db,
title = "Musculoskeletal tissue engineering by endogenous stem/progenitor cells",
abstract = "From its inception, tissue engineering has had three tenets: cells, biomaterial scaffolds and signaling molecules. Among the triad, cells are the center piece, because cells are the building blocks of tissues. For decades, cell therapies have focused on the procurement, manipulation and delivery of healthy cells for the treatment of diseases or trauma. Given the complexity and potential high cost of cell delivery, there is recent and surging interest to orchestrate endogenous cells for tissue regeneration. Biomaterial scaffolds are vital for many but not all, tissue-engineering applications and serve to accommodate or promote multiple cellular functions. Signaling molecules can be produced by transplanted cells or endogenous cells, or delivered specifically to regulate cell functions. This review highlights recent work in tissue engineering and cell therapies, with a focus on harnessing the capacity of endogenous cells as an alternative or adjunctive approach for tissue regeneration.",
keywords = "Cell delivery, Cell homing, Progenitor cells, Stem cells, Tissue engineering, Tissue regeneration",
author = "Hemin Nie and Lee, {Chang Hun} and Jiali Tan and Chuanyong Lu and Avital Mendelson and Mo Chen and Embree, {Mildred C.} and Kimi Kong and Bhranti Shah and Shuang Wang and Shoko Cho and Jeremy Mao",
year = "2012",
month = "3",
day = "1",
doi = "10.1007/s00441-012-1339-2",
language = "English (US)",
volume = "347",
pages = "665--676",
journal = "Cell and Tissue Research",
issn = "0302-766X",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Musculoskeletal tissue engineering by endogenous stem/progenitor cells

AU - Nie, Hemin

AU - Lee, Chang Hun

AU - Tan, Jiali

AU - Lu, Chuanyong

AU - Mendelson, Avital

AU - Chen, Mo

AU - Embree, Mildred C.

AU - Kong, Kimi

AU - Shah, Bhranti

AU - Wang, Shuang

AU - Cho, Shoko

AU - Mao, Jeremy

PY - 2012/3/1

Y1 - 2012/3/1

N2 - From its inception, tissue engineering has had three tenets: cells, biomaterial scaffolds and signaling molecules. Among the triad, cells are the center piece, because cells are the building blocks of tissues. For decades, cell therapies have focused on the procurement, manipulation and delivery of healthy cells for the treatment of diseases or trauma. Given the complexity and potential high cost of cell delivery, there is recent and surging interest to orchestrate endogenous cells for tissue regeneration. Biomaterial scaffolds are vital for many but not all, tissue-engineering applications and serve to accommodate or promote multiple cellular functions. Signaling molecules can be produced by transplanted cells or endogenous cells, or delivered specifically to regulate cell functions. This review highlights recent work in tissue engineering and cell therapies, with a focus on harnessing the capacity of endogenous cells as an alternative or adjunctive approach for tissue regeneration.

AB - From its inception, tissue engineering has had three tenets: cells, biomaterial scaffolds and signaling molecules. Among the triad, cells are the center piece, because cells are the building blocks of tissues. For decades, cell therapies have focused on the procurement, manipulation and delivery of healthy cells for the treatment of diseases or trauma. Given the complexity and potential high cost of cell delivery, there is recent and surging interest to orchestrate endogenous cells for tissue regeneration. Biomaterial scaffolds are vital for many but not all, tissue-engineering applications and serve to accommodate or promote multiple cellular functions. Signaling molecules can be produced by transplanted cells or endogenous cells, or delivered specifically to regulate cell functions. This review highlights recent work in tissue engineering and cell therapies, with a focus on harnessing the capacity of endogenous cells as an alternative or adjunctive approach for tissue regeneration.

KW - Cell delivery

KW - Cell homing

KW - Progenitor cells

KW - Stem cells

KW - Tissue engineering

KW - Tissue regeneration

UR - http://www.scopus.com/inward/record.url?scp=84862776942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862776942&partnerID=8YFLogxK

U2 - 10.1007/s00441-012-1339-2

DO - 10.1007/s00441-012-1339-2

M3 - Review article

C2 - 22382390

AN - SCOPUS:84862776942

VL - 347

SP - 665

EP - 676

JO - Cell and Tissue Research

JF - Cell and Tissue Research

SN - 0302-766X

IS - 3

ER -